Remimazolam mitigates cerebral ischemia/reperfusion injury by concurrently alleviating damage to the blood-brain barrier and RIP3/MLKL-driven necroptosis

International Immunopharmacology 2026

View at publisher
Authors: Zhihui Wang, Ruikun Zhang, Dong Qin Dai, Meiling Zhang, Dapeng Gao, Jie M. Zhang, Zhifang Wu, Kangli Hui, Jingwei Xiong, Hao Cheng, Jiali Xu, Qing Ji
DOI: 10.1016/j.intimp.2026.116182
Cited by: 2
References: 51

Fields of Study & Subjects

Inflammasome and immune disorders Neuroinflammation and Neurodegeneration Mechanisms Cell death mechanisms and regulation

Publication details

Journal / source
International Immunopharmacology
Publisher
Elsevier BV
Volume
172
Pages
116182–116182
Publication date
10 January 2026
Language
EN